ocio che frana un'altra volta. Motivo?
emissione di carta
Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules
13/01/2021 22:05 RSF
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getne...rs.com:20210113:nGNX5ZjRbs&default-theme=true
CHATHAM, N.J., Jan. 13, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering, priced at-the-market, with gross proceeds of $40.0 million before deducting fees and other estimated offering expenses.
The Company sold 50,000,000 shares of common stock at $0.80 per share.
A.G.P./Alliance Global Partners acted as sole placement agent for the offering.
This offering was made pursuant to effective shelf registration statements on Form S-3 (File No. 333-224586 and 333-237610) previously filed and declared effective by the U.S. Securities and Exchange Commission (the “SEC”). This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A final prospectus relating to the offering was filed with the SEC on January 12, 2021 and is available on the SEC’s website located at
SEC.gov | HOME. Copies of the prospectus supplement, together with the accompanying prospectuses, can be obtained at the SEC’s website at
SEC.gov | HOME or from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, New York 10022 or by email at
prospectus@allianceg.com.
